[1]
Zade, M. 2024. Targeting Neurodegeneration in Alzheimer’s Disease: A Comprehensive Evaluation of Andrographolide as a Potential Therapeutic Agent in the Management and Treatment of Cognitive Decline. Journal of Internal Medicine and Pharmacology (JIMP). 1, 02 (Aug. 2024), 20–32. DOI:https://doi.org/10.61920/jimp.v1i02.24.